Skip to main content

Table 6 Multiple regression analyses accounting for factors that affect total pill burden and pill burden from PBs

From: Prescription characteristics of phosphate binders in a high pill burden for hemodialysis patients

  

Model 1

Model 2

Total pill burden

(pills/day/patient)

Pill burden from PBs

(pills/day/patient)

Total pill burden

(pills/day/patient)

Pill burden from PBs

(pills/day/patient)

Gender (male)

β

(P)

 

0.097

0.040

  

Age (years)

β

(P)

- 0.110

0.011

- 0.250

< 0.001

- 0.090

0.037

- 0.255

< 0.001

Dialysis vintage (years)

β

(P)

0.290

< 0.001

0.175

< 0.001

0.220

< 0.001

0.145

0.003

DM (yes)

β

(P)

0.135

0.003

 

0.141

0.001

 

Serum P (mg/dL)

β

(P)

0.210

< 0.001

0.144

0.003

0.196

< 0.001

0.140

0.004

Oral calcimimetics (user)

β

(P)

  

0.175

<0.001

0.106

0.032

IV calcimimetics (user)

β

(P)

  

0.094

0.034

 
  1. Independent variables in model 1; gender (male), age (years), dialysis vintage (years), DM (yes), serum corrected Ca (mg/dL), serum P (mg/dL), serum i-PTH (pg/mL), serum Alb (g/dL), and nPCR (g/kg/day). Independent variables in model 2; model 1 + oral calcimimetics (user), IV calcimimetics (user), oral VDRAs (user), and IV VDRAs (user)